Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Perspective Therapeutics (CATX) Return on Capital Employed (2016 - 2026)

Perspective Therapeutics' Return on Capital Employed history spans 15 years, with the latest figure at 39.04% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 813.0% to 39.04% in Q1 2026 year-over-year; TTM through Mar 2026 was 39.04%, a 813.0% decrease, with the full-year FY2025 number at 41.24%, up 391.0% from a year prior.
  • Return on Capital Employed hit 39.04% in Q1 2026 for Perspective Therapeutics, up from 45.03% in the prior quarter.
  • Over the last five years, Return on Capital Employed for CATX hit a ceiling of 6.09% in Q1 2022 and a floor of 46.24% in Q4 2023.
  • Historically, Return on Capital Employed has averaged 27.16% across 5 years, with a median of 25.45% in 2024.
  • Biggest five-year swings in Return on Capital Employed: soared 2012bps in 2024 and later tumbled -2610bps in 2025.
  • Tracing CATX's Return on Capital Employed over 5 years: stood at 23.27% in 2022, then plummeted by -99bps to 46.24% in 2023, then skyrocketed by 44bps to 26.12% in 2024, then crashed by -72bps to 45.03% in 2025, then grew by 13bps to 39.04% in 2026.
  • Business Quant data shows Return on Capital Employed for CATX at 39.04% in Q1 2026, 45.03% in Q4 2025, and 42.07% in Q3 2025.